Surfacide Unveils Helios®+ UV-C System: The First Whole Room Microbial Reduction Device to Receive 510(k) Clearance from the U.S. Food and Drug Administration

▤ Summary

Surfacide launched Helios+ UV-C System and said it became the first whole-room microbial reduction device to receive FDA 510(k) clearance. The system uses three emitters in a single cycle to reduce microbial contamination in unoccupied hospital and operating rooms without repositioning. Surfacide also highlighted LTE connectivity, cloud support, safety sensors, and software and cyber security testing as part of the device package. The company positions Helios+ as a faster, more adaptable infection-prevention tool for healthcare facilities worldwide.

▦ Linked Companies

Surfacide

$5M to $10M